171 related articles for article (PubMed ID: 11511149)
21. [Selective estrogen receptor modulators].
Zasławski R; Surowiak P; Zabel M
Pol Arch Med Wewn; 2004 Nov; 112(5):1393-8. PubMed ID: 15773525
[No Abstract] [Full Text] [Related]
22. Breast cancer chemoprevention: a review of selective estrogen receptor modulators.
Johansen AM
Clin J Oncol Nurs; 2005 Jun; 9(3):317-20. PubMed ID: 15973842
[TBL] [Abstract][Full Text] [Related]
23. Medications for Primary Prevention of Breast Cancer.
Shieh Y; Tice JA
JAMA; 2020 Jul; 324(3):291-292. PubMed ID: 32692377
[No Abstract] [Full Text] [Related]
24. Chemoprevention of breast cancer: recommendations and rationale.
U.S. Preventive Services Task Force
Ann Intern Med; 2002 Jul; 137(1):56-8. PubMed ID: 12093249
[No Abstract] [Full Text] [Related]
25. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.
Vogel VG; Costantino JP; Wickerham DL; Cronin WM; Cecchini RS; Atkins JN; Bevers TB; Fehrenbacher L; Pajon ER; Wade JL; Robidoux A; Margolese RG; James J; Lippman SM; Runowicz CD; Ganz PA; Reis SE; McCaskill-Stevens W; Ford LG; Jordan VC; Wolmark N;
JAMA; 2006 Jun; 295(23):2727-41. PubMed ID: 16754727
[TBL] [Abstract][Full Text] [Related]
26. Selective estrogen receptor modulation and reduction in risk of breast cancer, osteoporosis, and coronary heart disease.
Jordan VC; Gapstur S; Morrow M
J Natl Cancer Inst; 2001 Oct; 93(19):1449-57. PubMed ID: 11584060
[TBL] [Abstract][Full Text] [Related]
27. The selective estrogen receptor modulators in breast cancer prevention.
Li F; Dou J; Wei L; Li S; Liu J
Cancer Chemother Pharmacol; 2016 May; 77(5):895-903. PubMed ID: 26787504
[TBL] [Abstract][Full Text] [Related]
28. CORE breast-cancer prevention trial.
Bradbury J
Lancet Oncol; 2005 Jan; 6(1):8. PubMed ID: 15672490
[No Abstract] [Full Text] [Related]
29. ACOG Practice Bulletin: Clinical Management Guidelines for Obstetrician-Gynecologists: Number 39, October 2002. Selective estrogen receptor modulators.
American College of Obstetricians and Gynecologists
Obstet Gynecol; 2002 Oct; 100(4):835-43. PubMed ID: 12387278
[No Abstract] [Full Text] [Related]
30. Raloxifene for breast cancer prevention.
Plouffe L
JAMA; 2001 Apr; 285(16):2079. PubMed ID: 11311092
[No Abstract] [Full Text] [Related]
31. Raloxifene examined for breast cancer prevention.
Young D
Am J Health Syst Pharm; 2007 Sep; 64(17):1774. PubMed ID: 17724350
[No Abstract] [Full Text] [Related]
32. ACOG practice bulletin. Selective estrogen receptor modulators. Number 39, October 2002 (replaces Committee Opinion Number 224, October 1999).
American College of Obsterticians and Gynecologists Committee on Practice Bulletins-Gynecology
Int J Gynaecol Obstet; 2002 Dec; 79(3):289-98. PubMed ID: 12501867
[TBL] [Abstract][Full Text] [Related]
33. [What do we think about selective estrogen receptor modulators?].
Cortet B
Rev Med Interne; 2001 Dec; 22(12):1173-6. PubMed ID: 11794886
[No Abstract] [Full Text] [Related]
34. Breast cancer chemoprevention: current status and future directions.
Wickerham DL; Tan-Chiu E
Semin Oncol; 2001 Jun; 28(3):253-9. PubMed ID: 11402435
[TBL] [Abstract][Full Text] [Related]
35. Summaries for patients. Using medication to prevent breast cancer: recommendations from the United States Preventive Services Task Force.
Ann Intern Med; 2002 Jul; 137(1):I62. PubMed ID: 12093267
[No Abstract] [Full Text] [Related]
36. Upstaging tamoxifen? New classes of drugs emerging for breast cancer.
Twombly R
J Natl Cancer Inst; 2002 Apr; 94(7):474-5. PubMed ID: 11929942
[No Abstract] [Full Text] [Related]
37. [Molecular mechanism tissue-specific actions of selective estrogen receptor modulators].
Urano T
Nihon Ronen Igakkai Zasshi; 2006 Mar; 43(2):147-51. PubMed ID: 16683636
[No Abstract] [Full Text] [Related]
38. SERMs for the treatment and prevention of breast cancer.
Swaby RF; Sharma CG; Jordan VC
Rev Endocr Metab Disord; 2007 Sep; 8(3):229-39. PubMed ID: 17440819
[TBL] [Abstract][Full Text] [Related]
39. Raloxifene and endometrial cancer.
Sismondi P; Biglia N; Ujcic E; Ponzone R; Roagna R
Tumori; 2001; 87(5):S18-9. PubMed ID: 11765199
[No Abstract] [Full Text] [Related]
40. Toward optimal health: advances in breast cancer detection and management. Interview by Jodi R. Godfrey.
Chlebowski RT
J Womens Health (Larchmt); 2008 Sep; 17(7):1067-70. PubMed ID: 18774890
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]